NYSE:BAX - Baxter International Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $74.75 +0.74 (+1.00 %) (As of 07/17/2018 04:00 PM ET)Previous Close$74.01Today's Range$73.73 - $74.8152-Week Range$58.81 - $75.62Volume2.70 million shsAverage Volume3.07 million shsMarket Capitalization$40.04 billionP/E Ratio29.92Dividend Yield1.02%Beta0.81 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. Receive BAX News and Ratings via Email Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical SymbolNYSE:BAX CUSIP07181310 Webwww.baxter.com Phone224-948-2000 Debt Debt-to-Equity Ratio0.39 Current Ratio2.63 Quick Ratio2.03 Price-To-Earnings Trailing P/E Ratio29.92 Forward P/E Ratio25.87 P/E Growth1.93 Sales & Book Value Annual Sales$10.56 billion Price / Sales3.79 Cash Flow$3.9198 per share Price / Cash19.07 Book Value$16.73 per share Price / Book4.47 Profitability EPS (Most Recent Fiscal Year)$2.48 Net Income$717 million Net Margins7.75% Return on Equity15.70% Return on Assets8.44% Miscellaneous Employees47,000 Outstanding Shares535,490,000Market Cap$40,043.64 Baxter International (NYSE:BAX) Frequently Asked Questions What is Baxter International's stock symbol? Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX." How often does Baxter International pay dividends? What is the dividend yield for Baxter International? Baxter International declared a quarterly dividend on Tuesday, July 17th. Stockholders of record on Friday, August 31st will be paid a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.02%. View Baxter International's Dividend History. How will Baxter International's stock buyback program work? Baxter International announced that its Board of Directors has approved a share repurchase program on Wednesday, February 21st 2018, which authorizes the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board of directors believes its stock is undervalued. How were Baxter International's earnings last quarter? Baxter International Inc (NYSE:BAX) announced its quarterly earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.62 by $0.08. The medical instruments supplier had revenue of $2.68 billion for the quarter, compared to the consensus estimate of $2.62 billion. Baxter International had a net margin of 7.75% and a return on equity of 15.70%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.58 earnings per share. View Baxter International's Earnings History. When is Baxter International's next earnings date? Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International. What guidance has Baxter International issued on next quarter's earnings? Baxter International issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS. What price target have analysts set for BAX? 16 equities research analysts have issued 12-month target prices for Baxter International's shares. Their predictions range from $62.00 to $83.00. On average, they anticipate Baxter International's stock price to reach $72.7333 in the next twelve months. This suggests that the stock has a possible downside of 2.7%. View Analyst Ratings for Baxter International. What is the consensus analysts' recommendation for Baxter International? 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of Baxter International's key competitors? Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN). Who are Baxter International's key executives? Baxter International's management team includes the folowing people: Mr. José E. Almeida, Chairman, Pres & CEO (Age 56)Mr. James K. Saccaro, Exec. VP & CFO (Age 45)Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 55)Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 54)Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 47) Has Baxter International been receiving favorable news coverage? Press coverage about BAX stock has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a media sentiment score of 0.14 on Accern's scale. They also assigned media stories about the medical instruments supplier an impact score of 45.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term. Who are Baxter International's major shareholders? Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.25%), Bank of Montreal Can (0.11%), Gateway Investment Advisers LLC (0.08%), NN Investment Partners Holdings N.V. (0.05%), Retirement Systems of Alabama (0.04%) and Gulf International Bank UK Ltd (0.03%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International. Which major investors are selling Baxter International stock? BAX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Bank of Montreal Can, Assenagon Asset Management S.A., Gateway Investment Advisers LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Retirement Systems of Alabama, CenturyLink Investment Management Co and Calamos Wealth Management LLC. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International. Which major investors are buying Baxter International stock? BAX stock was acquired by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Calamos Advisors LLC, Gulf International Bank UK Ltd, State of Alaska Department of Revenue, Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, DnB Asset Management AS and Xact Kapitalforvaltning AB. View Insider Buying and Selling for Baxter International. How do I buy shares of Baxter International? Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Baxter International's stock price today? One share of BAX stock can currently be purchased for approximately $74.75. How big of a company is Baxter International? Baxter International has a market capitalization of $40.04 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe. How can I contact Baxter International? Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected] MarketBeat Community Rating for Baxter International (NYSE BAX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 517 (Vote Outperform)Underperform Votes: 453 (Vote Underperform)Total Votes: 970MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: Do closed-end mutual funds pay dividends?